A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer
Clinical trial NCT05027139 · COMPLETED
Trial details
- NCT number
- NCT05027139
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2025-08-29
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.